PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Onyx Scientific Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Process Development Expertise Positions Onyx Scientific As Preferred Chemistry Services Provider - Whether developing a new process or improving an existing synthetic route, Onyx Scientific develop processes that are entirely practical with reduced synthetic steps and costs
Process Development Expertise Positions Onyx Scientific As Preferred Chemistry Services Provider

 

NewswireToday - /newswire/ - Sunderland, Tyne and Wear, United Kingdom, 2010/05/28 - Whether developing a new process or improving an existing synthetic route, Onyx Scientific develop processes that are entirely practical with reduced synthetic steps and costs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Onyx Scientific Ltd, the premier provider of outsourcing chemistry services, credits its problem-solving Process Development expertise and custom organic synthesis capability for its growing reputation as the preferred chemistry services provider within the custom synthesis market.

A research-driven and customer-focused company, Onyx Scientific provide pharmaceutical and biotechnology companies a broad and integrated portfolio of contract chemistry services throughout the drug discovery and development process, services that include: Process Development, Custom Synthesis, GMP synthesis and Scale-up, Analytical and Solid-State services, automated Salt Selection and Polymorphism screening studies.

Good Manufacturing Practice (GMP) and the development of reproducible Active Pharmaceutical Ingredients (APIs) require a clear understanding of chemical route selection, the development of a scalable GMP process and the generation and protection of intellectual property.

CEO, Tony Flinn comments, “whether developing a new process or improving an existing synthetic route, Onyx Scientific will aim to develop a process that is entirely practical with reduced synthetic steps and costs. In parallel, we conduct multi-step analysis to validate a process as scalable, reproducible and above all safe. We will try to eliminate toxic reagents, avoid chromatography and minimise waste. Solvents are chosen with regard to their residual effects and for new APIs we ensure ICH guidelines are followed. Where possible, we ensure that sustainable processes are developed using 'green chemistry' and we will work to convert stoichiometric processes to catalytic processes”.

Expert in medicinal chemistry, with multi-kilo GMP scale-up capability, Onyx Scientifics’ Process Development services include:

• Chemical route selection and economic modelling
• Selection of starting materials
• Method development and impurity identification
• Process optimization and Scale-up
• Assessment of process robustness
• Process validation and documentation
• Technology transfer.

Responsive to patent expirations and lean pipeline challenges, Onyx Scientific provide both dedicated FTE and fee-for-service resource with full transparency and flexibility to switch resource on and off as needed and at short notice.

MHRA certified, Onyx Scientifics’ state-of-the-art facility conforms to international GMP standards for the development of active pharmaceutical ingredients.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Onyx Scientific Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Process Development Expertise Positions Onyx Scientific As Preferred Chemistry Services Provider

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sue Jones - Onyx-Scientific.com 
+44 191 516 6516 suejones[.]onyx-scientific.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Onyx Scientific Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Onyx Scientific Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)